hiv-1

Documents about hiv-1

• Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults#143655ClinicalTrials.gov
• A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1#980435ClinicalTrials.gov
• Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1#907842ClinicalTrials.gov
• Safety and Effectiveness of a Combination Anti-HIV Drug Treatment#847826ClinicalTrials.gov
• The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients#881286ClinicalTrials.gov
• A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines#261339ClinicalTrials.gov
• Crosslinked HIV-1 cores TRIM5α#363473CaltechDATA
• Crosslinked HIV-1 cores TRIM5α#363491CaltechDATA
• Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT#474819ClinicalTrials.gov
• Combination of Efavirenz and Truvada - COMET Study#842691ClinicalTrials.gov
• Quality of Life of Taiwan People Living With HIV#849481ClinicalTrials.gov
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women#827312ClinicalTrials.gov
• Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients#869001ClinicalTrials.gov
• UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection#904695ClinicalTrials.gov
• Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children#916218ClinicalTrials.gov
• A Comparison of 141W94 and Indinavir in HIV-Infected Patients#805998ClinicalTrials.gov
• A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa#812200ClinicalTrials.gov
• A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium#830095ClinicalTrials.gov
• A Study to Test Three Experimental HIV Vaccines in Healthy Adults.#833386ClinicalTrials.gov
• PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection#867001ClinicalTrials.gov
• Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus#887823ClinicalTrials.gov
• Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients#994111ClinicalTrials.gov
• Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults#831554ClinicalTrials.gov
• Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men#226352ClinicalTrials.gov
• A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection#841431ClinicalTrials.gov
• Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations#836125ClinicalTrials.gov
• Inflammation, NK Cells, Antisense Protein and Exosomes, and Correlation With Immune Response During HIV Infection#893915ClinicalTrials.gov
• The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients#903227ClinicalTrials.gov
• Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection#979562ClinicalTrials.gov
• HIV-1 - HOST-CENTRIC SEQUESTRATION PARADIGM SCIENTIFIC VALIDATION & HIV CURE PATH. AN ADVANCED LOGICAL SYNTHESIS & EMPIRICAL VALIDATION OF HIV-1 LATENCY AS ACTIVE CELLULAR SELF-PRESERVATION - QUIESCENCE CD4+ T CELLS#990605Zenodo (CERN)
• HIV Adherence Bottle Intervention Trial#979343ClinicalTrials.gov
• Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults#876329ClinicalTrials.gov
• A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1#827529ClinicalTrials.gov
• PrEPsmart 2-1-1 Pilot#1010908ClinicalTrials.gov
• Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV)#825558ClinicalTrials.gov
• Immunogenetic Modulators of Mucosal Protection From HIV-1#891430ClinicalTrials.gov
• Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition#899037ClinicalTrials.gov
• The Prevalence of Neurocognitive Disorder in a Primary Care-based HIV Cohort Compared to a HIV-negative Control Cohort -#858195ClinicalTrials.gov
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients#870265ClinicalTrials.gov
• Lenacapavir Use in France: A National, Observational Study (LENAddOn)#677181HAL (France)
• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults#979615ClinicalTrials.gov
• Acute Coronary Syndrome KCMC_1#154775ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers#876408ClinicalTrials.gov
• Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients#909047ClinicalTrials.gov
• Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment#914818ClinicalTrials.gov
• A snapshot of HIV-1 genetic diversity in Dominican Republic in 2024: Predominance of the B_Car lineage and first description of a CRF02-AG isolate#165983PLOS
• A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies#856678ClinicalTrials.gov
• Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial#877981ClinicalTrials.gov
• Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients#916216ClinicalTrials.gov
• A Study of LXR015-1 in HIV-Infected Patients#810596ClinicalTrials.gov